Armata Pharmaceuticals, Inc. (ARMP) Financials

Armata Pharmaceuticals, Inc. (ARMP) financial statements and ratios from SEC XBRL: revenue $179000.00 (TTM), net margin -38572.6%. Income statement, balance sheet, cash flow, and valuation. First-party data.

Financials — source: SEC XBRL
Revenue (TTM)$179000.00
Net Margin-38572.6%
Price / Sales485.86
FCF Yield-14.0%
Sector P/E (Healthcare)21.7

ARMP overview · ARMP earnings · ARMP KPIs · ARMP investor relations · ARMP ownership · ARMP peers · ARMP filings

Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.